Previous 10 | Next 10 |
2023-03-08 07:43:51 ET WW International ( NASDAQ: WW ) stock slid over 10% in pre-market trading on Wednesday, giving back some gains from its 79% run on Tuesday. While Craig Hallum analyst Alex Fuhrman acknowledged that the Sequence acquisition could spark upside fo...
2023-03-08 07:02:07 ET Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify S&P, Nasdaq, Dow futures tick up as market braces for the return of Powell (1:00). Senators unveil bill to rein in TikTok ( BDNCE ), 'adv...
2023-03-08 04:54:03 ET Summary WW's announcement of an acquisition entering the telehealth segment with a focus on weight loss drugs may be a game changer. The deal with "Sequence" works as a good strategy reset to revitalize growth following a period of declining membership and w...
2023-03-07 18:27:09 ET Stocks finished sharply lower on Tuesday, weighed down by hawkish comments from Federal Reserve Chair Jerome Powell. The Dow led the major averages lower, falling by 1.7%. Looking at individual stocks, WW International ( NASDAQ: WW ) jumped almost 80% afte...
2023-03-07 12:39:41 ET Gainers: ThredUp ( TDUP ) +73% . WW International ( WW ) +49% . Unicycive ( UNCY ) +39% . Protagonist Therapeutics ( PTGX ) +32% . Bionomics ( BNOX ) +28% . Novo Integrated Sciences ( NVOS ) +25% ...
2023-03-07 11:42:02 ET Gainers: ThredUp ( TDUP ) +61% . WW International ( WW ) +39% . Gaia ( GAIA ) +28% . Sea Limited ( SE ) +17% . ATA Creativity Global ( AACG ) +16% . Losers: Troika Media ( TRKA ) -25% . ...
2023-03-07 11:01:48 ET WW International ( NASDAQ: WW ) shares surged over 40% on Tuesday as a new acquisition overshadowed a mixed earnings result. The weight loss company missed on top and bottom lines for the fourth quarter as revenue fell nearly 20% year over ...
2023-03-07 08:38:30 ET ThredUp ( TDUP ) +17% on Q4 earnings . Protagonist Therapeutics ( NASDAQ: PTGX ) +20% on positive topline results for Phase 2b FRONTIER 1 clinical trial of Oral IL-23 Receptor Antagonist JNJ-2113 (PN-235) in Psoriasis. BYND Cannas...
2023-03-07 07:06:01 ET Listen on the go! Subscribe to Wall Street Breakfast on Apple Podcasts and Spotify Investors eye Powell's Senate testimony for rate hike clues amid hot economic data (00:48). Meta Platforms ( META ) is reportedly ready to cut thou...
2023-03-06 20:10:04 ET WW International, Inc. (WW) Q4 2022 Results Conference Call March 06, 2023 05:00 PM ET Company Participants Corey Kinger - Investor Relations Sima Sistani - Chief Executive Officer Heather Stark - Interim Principal Financial Officer C...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 07:00:08 ET Nathan Feather from Morgan Stanley issued a price target of $1.25 for WW on 2024-07-26 05:48:00. The adjusted price target was set to $1.25. At the time of the announcement, WW was trading at $1.32. The overall price target consensus is at $6.00 wi...
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the second quarter 2024 before market open on Thursday, August 1, 2024. WeightWatchers will host ...